Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study
Ji Eun Park, Kyung Soo Hong, Sun Ha Choi, Shin Yup Lee, Kyeong‐Cheol Shin, Jong Geol Jang, Yong Shik Kwon, Sun Hyo Park, Keum-Ju Choi, Chi Young Jung, Jung Seop Eom, Saerom Kim, Hee Yun Seol, Jehun Kim, Insu Kim, Jin Han Park, Tae Hoon Kim, June Hong Ahn
Topics & Concepts
MedicineDurvalumabChemoradiotherapyMulticenter studyStage (stratigraphy)OncologyInternal medicineRadiation therapyCancerPembrolizumabRandomized controlled trialImmunotherapyPaleontologyBiologyLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations